Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H2E6
UPID:
SEM6A_HUMAN
Alternative names:
Semaphorin VIA; Semaphorin-6A-1
Alternative UPACC:
Q9H2E6; Q9P2H9
Background:
Semaphorin-6A, also known as Semaphorin VIA or Semaphorin-6A-1, is a pivotal cell surface receptor for PLXNA2, essential for cell-cell signaling. It plays a crucial role in the migration of granule cells in the developing cerebellum, axon guidance, and the reorganization of the actin cytoskeleton in the central nervous system. Its ability to act as a repulsive cue for axon guidance and granular neuron migration underscores its significance in neural development.
Therapeutic significance:
Understanding the role of Semaphorin-6A could open doors to potential therapeutic strategies, particularly in addressing developmental disorders of the nervous system and improving outcomes in neural repair and regeneration.